[Histamine-like compounds with cyclicized side chain. 1. Report on structure-activity relationships of histamine analogs]. - Suppr | 超能文献

[Histamine-like compounds with cyclicized side chain. 1. Report on structure-activity relationships of histamine analogs].

作者信息

Schunack W

出版信息

Arch Pharm (Weinheim). 1973 Dec;306(12):934-42. doi: 10.1002/ardp.19733061208.

DOI:10.1002/ardp.19733061208

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Histamine-like compounds with cyclicized side chain. 1. Report on structure-activity relationships of histamine analogs].

Arch Pharm (Weinheim). 1973 Dec;306(12):934-42. doi: 10.1002/ardp.19733061208.

2

Proceedings: Structure-action-relationships of histamine analogues.论文集：组胺类似物的构效关系

Naunyn Schmiedebergs Arch Pharmacol. 1974;282(Suppl):suppl 282:R90.

3

Potencies of antagonists chemically related to iodoproxyfan at histamine H3 receptors in mouse brain cortex and guinea-pig ileum: evidence for H3 receptor heterogeneity?与碘普罗芬化学相关的拮抗剂在小鼠大脑皮层和豚鼠回肠组胺H3受体上的效能：H3受体异质性的证据？

Naunyn Schmiedebergs Arch Pharmacol. 1996 Apr;353(5):482-8. doi: 10.1007/BF00169166.

4

Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists.构象受限组胺H(3)受体激动剂的合成及构效关系

J Med Chem. 2003 Dec 4;46(25):5445-57. doi: 10.1021/jm030905y.

5

Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold.基于4-[(1H-咪唑-4-基)甲基]哌啶骨架的新型组胺H3受体拮抗剂。

Bioorg Med Chem Lett. 2006 Jan 15;16(2):395-9. doi: 10.1016/j.bmcl.2005.09.076. Epub 2005 Oct 21.

6

Diether derivatives of homo- or substituted piperidines as non-imidazole histamine H3 receptor ligands.高哌啶或取代哌啶的二乙醚衍生物作为非咪唑类组胺H3受体配体。

Bioorg Med Chem. 2009 Apr 15;17(8):3037-42. doi: 10.1016/j.bmc.2009.03.014. Epub 2009 Mar 14.

7

[Structure-activity relationship in histamine analogs. 14. 4-(aminomethyl)benzimidazoles and 9-aminonaphth/1,2-d/imidazoles].[组胺类似物的构效关系。14. 4-(氨甲基)苯并咪唑和9-氨基萘并[1,2-d]咪唑]

Arch Pharm (Weinheim). 1977 Jun;310(6):455-60. doi: 10.1002/ardp.19773100603.

8

Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain.组胺 H3 受体结合部位的研究。具有亲脂侧链的混合激动剂的设计与合成。

J Med Chem. 2010 Sep 9;53(17):6445-56. doi: 10.1021/jm100643t.

9

The synthesis and structure-activity relationship of 4-benzimidazolyl-piperidinylcarbonyl-piperidine analogs as histamine H3 antagonists.4-苯并咪唑基-哌啶基羰基-哌啶类似物作为组胺 H3 拮抗剂的合成及构效关系。

Bioorg Med Chem Lett. 2010 Sep 1;20(17):5004-8. doi: 10.1016/j.bmcl.2010.07.052. Epub 2010 Jul 16.

10

The histamine H2 receptor agonist impromidine: synthesis and structure-activity considerations.

J Med Chem. 1985 Oct;28(10):1414-22. doi: 10.1021/jm00148a007.

引用本文的文献

1

Pharmacological activity of new histamine analogues.新型组胺类似物的药理活性。

Agents Actions. 1974 Aug;4(3):195. doi: 10.1007/BF01970273.

2

H3 receptor antagonist, thioperamide, inhibits adrenal steroidogenesis and histamine binding to adrenocortical microsomes and binds to cytochrome P450.H3受体拮抗剂硫代丙酰胺可抑制肾上腺类固醇生成，抑制组胺与肾上腺皮质微粒体的结合，并与细胞色素P450结合。

Br J Pharmacol. 1992 Sep;107(1):161-4. doi: 10.1111/j.1476-5381.1992.tb14480.x.